Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5′ non-coding region of the bcl-6 gene View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2001-04

AUTHORS

M-S Mateo, M Mollejo, R Villuendas, P Algara, M Sanchez-Beato, P Martínez, MA Piris

ABSTRACT

Splenic marginal zone lymphoma (SMZL) has been recognized as a distinctive type of small B cell lymphoma, and defined on the basis of its morphological, phenotypic, clinical and molecular characteristics. In spite of this, the borders of the entity, the homogeneity of the cases and the presumably cell origin of SMZL remain controversial issues. The frequency of mutation in the 5′ non-coding region of the bcl-6 gene has been used as a marker of germinal center derivation, which may be used to establish the molecular heterogeneity of different non-Hodgkin lymphoma (NHL) types. This roughly parallels the characteristics and frequency of the somatic hypermutations found in the immunoglobulin heavy chain variable region (IgVH) genes. This study analyzed mutations of bcl-6 in the 5′ non-coding region in 22 SMZL cases and, for the purpose of comparison with different B cell subsets, in microdissected germinal centers, mantle zones and marginal zone subpopulations from reactive splenic lymphoid follicles. A majority of the SMZL cases studied, 19/22 (87%), bear unmutated bcl-6 gene, while mutation was only observed in 3/22 (13%) cases. Analysis of normal B cell subpopulations showed bcl-6 hypermutation in 3/10 (30%) germinal center clones, 5/14 (35%) marginal zone clones; and unmutated sequences in all clones derived from mantle cells. The frequency of these mutations in normal spleen confirms previous findings on the hypermutation IgVH process in normal B cell populations. The data presented here support the existence of molecular heterogeneity in this entity, and give additional results in favor of the hypothesis that, in spite of initial morphological observations, a significant proportion of SMZL cases could derive from an unmutated naive precursor, different from the marginal zone, and possibly located in the mantle zone of splenic lymphoid follicles. Thus the marginal zone differentiation of these tumors could be related more with the splenic microenvironment than it is to the histogenetic characteristics of the tumor. More... »

PAGES

628-634

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.leu.2402073

DOI

http://dx.doi.org/10.1038/sj.leu.2402073

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1033752642

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11368366


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "5' Untranslated Regions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ADP-ribosyl Cyclase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ADP-ribosyl Cyclase 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, CD", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Differentiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA-Binding Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Lymphocytic, Chronic, B-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, B-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Glycoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "NAD+ Nucleosidase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-bcl-6", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Splenic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcription Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Genetics, \u2018Virgen de la Salud\u2019 Hospital, Toledo, Spain", 
          "id": "http://www.grid.ac/institutes/grid.413514.6", 
          "name": [
            "Department of Genetics, \u2018Virgen de la Salud\u2019 Hospital, Toledo, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mateo", 
        "givenName": "M-S", 
        "id": "sg:person.07672372522.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07672372522.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, \u2018Virgen de la Salud\u2019 Hospital, Toledo, Spain", 
          "id": "http://www.grid.ac/institutes/grid.413514.6", 
          "name": [
            "Department of Pathology, \u2018Virgen de la Salud\u2019 Hospital, Toledo, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mollejo", 
        "givenName": "M", 
        "id": "sg:person.01053746063.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053746063.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro Nacional de Investigaciones Oncologicas, Programa de Patologia Molecular, Instituto de Salud Carlos III, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Centro Nacional de Investigaciones Oncologicas, Programa de Patologia Molecular, Instituto de Salud Carlos III, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Villuendas", 
        "givenName": "R", 
        "id": "sg:person.01174075722.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174075722.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Genetics, \u2018Virgen de la Salud\u2019 Hospital, Toledo, Spain", 
          "id": "http://www.grid.ac/institutes/grid.413514.6", 
          "name": [
            "Department of Genetics, \u2018Virgen de la Salud\u2019 Hospital, Toledo, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Algara", 
        "givenName": "P", 
        "id": "sg:person.01047434337.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047434337.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro Nacional de Investigaciones Oncologicas, Programa de Patologia Molecular, Instituto de Salud Carlos III, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Centro Nacional de Investigaciones Oncologicas, Programa de Patologia Molecular, Instituto de Salud Carlos III, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sanchez-Beato", 
        "givenName": "M", 
        "id": "sg:person.01026644115.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026644115.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Genetics, \u2018Virgen de la Salud\u2019 Hospital, Toledo, Spain", 
          "id": "http://www.grid.ac/institutes/grid.413514.6", 
          "name": [
            "Department of Genetics, \u2018Virgen de la Salud\u2019 Hospital, Toledo, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mart\u00ednez", 
        "givenName": "P", 
        "id": "sg:person.01153016346.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153016346.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro Nacional de Investigaciones Oncologicas, Programa de Patologia Molecular, Instituto de Salud Carlos III, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Centro Nacional de Investigaciones Oncologicas, Programa de Patologia Molecular, Instituto de Salud Carlos III, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Piris", 
        "givenName": "MA", 
        "id": "sg:person.07440427070.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07440427070.11"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.leu.2401766", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016032167", 
          "https://doi.org/10.1038/sj.leu.2401766"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/381751a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027266776", 
          "https://doi.org/10.1038/381751a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-04", 
    "datePublishedReg": "2001-04-01", 
    "description": "Splenic marginal zone lymphoma (SMZL) has been recognized as a distinctive type of small B cell lymphoma, and defined on the basis of its morphological, phenotypic, clinical and molecular characteristics. In spite of this, the borders of the entity, the homogeneity of the cases and the presumably cell origin of SMZL remain controversial issues. The frequency of mutation in the 5\u2032 non-coding region of the bcl-6 gene has been used as a marker of germinal center derivation, which may be used to establish the molecular heterogeneity of different non-Hodgkin lymphoma (NHL) types. This roughly parallels the characteristics and frequency of the somatic hypermutations found in the immunoglobulin heavy chain variable region (IgVH) genes. This study analyzed mutations of bcl-6 in the 5\u2032 non-coding region in 22 SMZL cases and, for the purpose of comparison with different B cell subsets, in microdissected germinal centers, mantle zones and marginal zone subpopulations from reactive splenic lymphoid follicles. A majority of the SMZL cases studied, 19/22 (87%), bear unmutated bcl-6 gene, while mutation was only observed in 3/22 (13%) cases. Analysis of normal B cell subpopulations showed bcl-6 hypermutation in 3/10 (30%) germinal center clones, 5/14 (35%) marginal zone clones; and unmutated sequences in all clones derived from mantle cells. The frequency of these mutations in normal spleen confirms previous findings on the hypermutation IgVH process in normal B cell populations. The data presented here support the existence of molecular heterogeneity in this entity, and give additional results in favor of the hypothesis that, in spite of initial morphological observations, a significant proportion of SMZL cases could derive from an unmutated naive precursor, different from the marginal zone, and possibly located in the mantle zone of splenic lymphoid follicles. Thus the marginal zone differentiation of these tumors could be related more with the splenic microenvironment than it is to the histogenetic characteristics of the tumor.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.leu.2402073", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1097065", 
        "issn": [
          "0887-6924", 
          "1476-5551"
        ], 
        "name": "Leukemia", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "15"
      }
    ], 
    "keywords": [
      "splenic marginal zone lymphoma", 
      "splenic lymphoid follicles", 
      "marginal zone lymphoma", 
      "lymphoid follicles", 
      "zone lymphoma", 
      "SMZL cases", 
      "mantle zone", 
      "molecular heterogeneity", 
      "marginal zone differentiation", 
      "germinal center derivation", 
      "cell subsets", 
      "BCL-6 gene", 
      "immunoglobulin heavy chain variable region genes", 
      "heavy chain variable region genes", 
      "cell lymphoma", 
      "lymphoma type", 
      "naive precursors", 
      "germinal centers", 
      "normal spleen", 
      "splenic microenvironment", 
      "cell origin", 
      "cell subpopulations", 
      "frequency of mutations", 
      "chain variable region genes", 
      "histogenetic characteristics", 
      "lymphoma", 
      "variable region genes", 
      "cell populations", 
      "mantle cell", 
      "significant proportion", 
      "tumors", 
      "follicles", 
      "marginal zone", 
      "Mutations of BCL-6", 
      "non-coding region", 
      "molecular characteristics", 
      "subpopulations", 
      "region genes", 
      "previous findings", 
      "zone differentiation", 
      "somatic hypermutation", 
      "mutations", 
      "analysis of mutations", 
      "controversial issue", 
      "unmutated sequences", 
      "cases", 
      "spleen", 
      "hypermutation", 
      "genes", 
      "BCL-6", 
      "entities", 
      "clones", 
      "markers", 
      "heterogeneity", 
      "microenvironment", 
      "frequency", 
      "cells", 
      "distinctive type", 
      "majority", 
      "findings", 
      "population", 
      "proportion", 
      "spite", 
      "subset", 
      "morphological observations", 
      "differentiation", 
      "study", 
      "center", 
      "types", 
      "phenotypic", 
      "characteristics", 
      "hypothesis", 
      "analysis", 
      "bcl-6 hypermutation", 
      "region", 
      "purpose", 
      "purpose of comparison", 
      "data", 
      "border", 
      "favor", 
      "comparison", 
      "origin", 
      "results", 
      "observations", 
      "basis", 
      "precursors", 
      "zone", 
      "Additional results", 
      "issues", 
      "sequence", 
      "homogeneity", 
      "process", 
      "existence", 
      "derivation", 
      "presumably cell origin", 
      "center derivation", 
      "different non-Hodgkin lymphoma (NHL) types", 
      "non-Hodgkin lymphoma (NHL) types", 
      "marginal zone subpopulations", 
      "zone subpopulations", 
      "reactive splenic lymphoid follicles", 
      "bear unmutated bcl-6 gene", 
      "unmutated bcl-6 gene", 
      "germinal center clones", 
      "center clones", 
      "marginal zone clones", 
      "zone clones", 
      "hypermutation IgVH process", 
      "IgVH process", 
      "initial morphological observations", 
      "unmutated naive precursor"
    ], 
    "name": "Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5\u2032 non-coding region of the bcl-6 gene", 
    "pagination": "628-634", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1033752642"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.leu.2402073"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11368366"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.leu.2402073", 
      "https://app.dimensions.ai/details/publication/pub.1033752642"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:11", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_323.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.leu.2402073"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2402073'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2402073'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2402073'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2402073'


 

This table displays all metadata directly associated to this object as RDF triples.

296 TRIPLES      22 PREDICATES      157 URIs      146 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.leu.2402073 schema:about N1df65d34af514532b0b286c8d54713d7
2 N25cb3d58142d44cf9b839ab42c0d7fdc
3 N26a8ffb4b3cc438480c5c0e4e74925bc
4 N3263465ff306407fad93b327dee27544
5 N3e4730807c5e449b9216d3892d6504b3
6 N3f709cb9e039427aaee77500b733ce7a
7 N4d970f58263a47f4835e47d7a1ce9500
8 N4ef5724e611c48bdb17e1078d17e6f06
9 N876e2c5425644820b99e5c9e35596438
10 Na105b016f0084dbda71f4727e56ec2f7
11 Nc2320c99f7d243ea92e2f606db6ec4ec
12 Nc6909a53f2a2493295b27235ddccad0c
13 Nc695539bdd5845578a79b44a12e4dd20
14 Nc82f22c20cf3406fa8d80aebc022762a
15 Nd92bb2215749453bb4a965bb76cd39dc
16 Ne708c887f0944773b97b203f377bc0be
17 anzsrc-for:11
18 anzsrc-for:1103
19 anzsrc-for:1112
20 schema:author N3113cd6339464d299770ae88d9796f37
21 schema:citation sg:pub.10.1038/381751a0
22 sg:pub.10.1038/sj.leu.2401766
23 schema:datePublished 2001-04
24 schema:datePublishedReg 2001-04-01
25 schema:description Splenic marginal zone lymphoma (SMZL) has been recognized as a distinctive type of small B cell lymphoma, and defined on the basis of its morphological, phenotypic, clinical and molecular characteristics. In spite of this, the borders of the entity, the homogeneity of the cases and the presumably cell origin of SMZL remain controversial issues. The frequency of mutation in the 5′ non-coding region of the bcl-6 gene has been used as a marker of germinal center derivation, which may be used to establish the molecular heterogeneity of different non-Hodgkin lymphoma (NHL) types. This roughly parallels the characteristics and frequency of the somatic hypermutations found in the immunoglobulin heavy chain variable region (IgVH) genes. This study analyzed mutations of bcl-6 in the 5′ non-coding region in 22 SMZL cases and, for the purpose of comparison with different B cell subsets, in microdissected germinal centers, mantle zones and marginal zone subpopulations from reactive splenic lymphoid follicles. A majority of the SMZL cases studied, 19/22 (87%), bear unmutated bcl-6 gene, while mutation was only observed in 3/22 (13%) cases. Analysis of normal B cell subpopulations showed bcl-6 hypermutation in 3/10 (30%) germinal center clones, 5/14 (35%) marginal zone clones; and unmutated sequences in all clones derived from mantle cells. The frequency of these mutations in normal spleen confirms previous findings on the hypermutation IgVH process in normal B cell populations. The data presented here support the existence of molecular heterogeneity in this entity, and give additional results in favor of the hypothesis that, in spite of initial morphological observations, a significant proportion of SMZL cases could derive from an unmutated naive precursor, different from the marginal zone, and possibly located in the mantle zone of splenic lymphoid follicles. Thus the marginal zone differentiation of these tumors could be related more with the splenic microenvironment than it is to the histogenetic characteristics of the tumor.
26 schema:genre article
27 schema:inLanguage en
28 schema:isAccessibleForFree true
29 schema:isPartOf N89cbc0dfaef0404883c1f397e430aa20
30 Nd9336acdd9484affb9216235f64ecd99
31 sg:journal.1097065
32 schema:keywords Additional results
33 BCL-6
34 BCL-6 gene
35 IgVH process
36 Mutations of BCL-6
37 SMZL cases
38 analysis
39 analysis of mutations
40 basis
41 bcl-6 hypermutation
42 bear unmutated bcl-6 gene
43 border
44 cases
45 cell lymphoma
46 cell origin
47 cell populations
48 cell subpopulations
49 cell subsets
50 cells
51 center
52 center clones
53 center derivation
54 chain variable region genes
55 characteristics
56 clones
57 comparison
58 controversial issue
59 data
60 derivation
61 different non-Hodgkin lymphoma (NHL) types
62 differentiation
63 distinctive type
64 entities
65 existence
66 favor
67 findings
68 follicles
69 frequency
70 frequency of mutations
71 genes
72 germinal center clones
73 germinal center derivation
74 germinal centers
75 heavy chain variable region genes
76 heterogeneity
77 histogenetic characteristics
78 homogeneity
79 hypermutation
80 hypermutation IgVH process
81 hypothesis
82 immunoglobulin heavy chain variable region genes
83 initial morphological observations
84 issues
85 lymphoid follicles
86 lymphoma
87 lymphoma type
88 majority
89 mantle cell
90 mantle zone
91 marginal zone
92 marginal zone clones
93 marginal zone differentiation
94 marginal zone lymphoma
95 marginal zone subpopulations
96 markers
97 microenvironment
98 molecular characteristics
99 molecular heterogeneity
100 morphological observations
101 mutations
102 naive precursors
103 non-Hodgkin lymphoma (NHL) types
104 non-coding region
105 normal spleen
106 observations
107 origin
108 phenotypic
109 population
110 precursors
111 presumably cell origin
112 previous findings
113 process
114 proportion
115 purpose
116 purpose of comparison
117 reactive splenic lymphoid follicles
118 region
119 region genes
120 results
121 sequence
122 significant proportion
123 somatic hypermutation
124 spite
125 spleen
126 splenic lymphoid follicles
127 splenic marginal zone lymphoma
128 splenic microenvironment
129 study
130 subpopulations
131 subset
132 tumors
133 types
134 unmutated bcl-6 gene
135 unmutated naive precursor
136 unmutated sequences
137 variable region genes
138 zone
139 zone clones
140 zone differentiation
141 zone lymphoma
142 zone subpopulations
143 schema:name Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5′ non-coding region of the bcl-6 gene
144 schema:pagination 628-634
145 schema:productId N4c0e445601864ce7b570c1de7a45ac98
146 Nba80fb3c2cc64470b4e100e46e2a7b93
147 Nff5f26206f4a4b7b917d7f049b97b6e9
148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033752642
149 https://doi.org/10.1038/sj.leu.2402073
150 schema:sdDatePublished 2021-12-01T19:11
151 schema:sdLicense https://scigraph.springernature.com/explorer/license/
152 schema:sdPublisher Ne94b66c03d924bc69af5bdf191ea3018
153 schema:url https://doi.org/10.1038/sj.leu.2402073
154 sgo:license sg:explorer/license/
155 sgo:sdDataset articles
156 rdf:type schema:ScholarlyArticle
157 N0127a2d119c642a190058946feb97eb7 rdf:first sg:person.07440427070.11
158 rdf:rest rdf:nil
159 N1df65d34af514532b0b286c8d54713d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name DNA-Binding Proteins
161 rdf:type schema:DefinedTerm
162 N25cb3d58142d44cf9b839ab42c0d7fdc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Proto-Oncogene Proteins
164 rdf:type schema:DefinedTerm
165 N26a8ffb4b3cc438480c5c0e4e74925bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Leukemia, Lymphocytic, Chronic, B-Cell
167 rdf:type schema:DefinedTerm
168 N30bbf1c71898437391e7927e9ad74164 rdf:first sg:person.01174075722.29
169 rdf:rest Ndca8043e5e874b9ca4d7f6e213d3fd9a
170 N3113cd6339464d299770ae88d9796f37 rdf:first sg:person.07672372522.34
171 rdf:rest Ne000290443d543809662e21e85b91304
172 N3263465ff306407fad93b327dee27544 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name 5' Untranslated Regions
174 rdf:type schema:DefinedTerm
175 N3e4730807c5e449b9216d3892d6504b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Humans
177 rdf:type schema:DefinedTerm
178 N3f709cb9e039427aaee77500b733ce7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Lymphoma, B-Cell
180 rdf:type schema:DefinedTerm
181 N4c0e445601864ce7b570c1de7a45ac98 schema:name dimensions_id
182 schema:value pub.1033752642
183 rdf:type schema:PropertyValue
184 N4d970f58263a47f4835e47d7a1ce9500 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Mutation
186 rdf:type schema:DefinedTerm
187 N4ef5724e611c48bdb17e1078d17e6f06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name NAD+ Nucleosidase
189 rdf:type schema:DefinedTerm
190 N519122ae62c642b68085e85e50a8d1ea rdf:first sg:person.01153016346.55
191 rdf:rest N0127a2d119c642a190058946feb97eb7
192 N876e2c5425644820b99e5c9e35596438 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Antigens, CD
194 rdf:type schema:DefinedTerm
195 N89cbc0dfaef0404883c1f397e430aa20 schema:volumeNumber 15
196 rdf:type schema:PublicationVolume
197 Na105b016f0084dbda71f4727e56ec2f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Transcription Factors
199 rdf:type schema:DefinedTerm
200 Nba80fb3c2cc64470b4e100e46e2a7b93 schema:name doi
201 schema:value 10.1038/sj.leu.2402073
202 rdf:type schema:PropertyValue
203 Nc2320c99f7d243ea92e2f606db6ec4ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Membrane Glycoproteins
205 rdf:type schema:DefinedTerm
206 Nc6909a53f2a2493295b27235ddccad0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
207 schema:name Antigens, Differentiation
208 rdf:type schema:DefinedTerm
209 Nc695539bdd5845578a79b44a12e4dd20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name ADP-ribosyl Cyclase
211 rdf:type schema:DefinedTerm
212 Nc82f22c20cf3406fa8d80aebc022762a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
213 schema:name Proto-Oncogene Proteins c-bcl-6
214 rdf:type schema:DefinedTerm
215 Nd92bb2215749453bb4a965bb76cd39dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
216 schema:name Splenic Neoplasms
217 rdf:type schema:DefinedTerm
218 Nd9336acdd9484affb9216235f64ecd99 schema:issueNumber 4
219 rdf:type schema:PublicationIssue
220 Ndca8043e5e874b9ca4d7f6e213d3fd9a rdf:first sg:person.01047434337.88
221 rdf:rest Nfb3b2efe2d6f44c8a4c8c354ed690187
222 Ne000290443d543809662e21e85b91304 rdf:first sg:person.01053746063.57
223 rdf:rest N30bbf1c71898437391e7927e9ad74164
224 Ne708c887f0944773b97b203f377bc0be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
225 schema:name ADP-ribosyl Cyclase 1
226 rdf:type schema:DefinedTerm
227 Ne94b66c03d924bc69af5bdf191ea3018 schema:name Springer Nature - SN SciGraph project
228 rdf:type schema:Organization
229 Nfb3b2efe2d6f44c8a4c8c354ed690187 rdf:first sg:person.01026644115.63
230 rdf:rest N519122ae62c642b68085e85e50a8d1ea
231 Nff5f26206f4a4b7b917d7f049b97b6e9 schema:name pubmed_id
232 schema:value 11368366
233 rdf:type schema:PropertyValue
234 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
235 schema:name Medical and Health Sciences
236 rdf:type schema:DefinedTerm
237 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
238 schema:name Clinical Sciences
239 rdf:type schema:DefinedTerm
240 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
241 schema:name Oncology and Carcinogenesis
242 rdf:type schema:DefinedTerm
243 sg:journal.1097065 schema:issn 0887-6924
244 1476-5551
245 schema:name Leukemia
246 schema:publisher Springer Nature
247 rdf:type schema:Periodical
248 sg:person.01026644115.63 schema:affiliation grid-institutes:None
249 schema:familyName Sanchez-Beato
250 schema:givenName M
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026644115.63
252 rdf:type schema:Person
253 sg:person.01047434337.88 schema:affiliation grid-institutes:grid.413514.6
254 schema:familyName Algara
255 schema:givenName P
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047434337.88
257 rdf:type schema:Person
258 sg:person.01053746063.57 schema:affiliation grid-institutes:grid.413514.6
259 schema:familyName Mollejo
260 schema:givenName M
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053746063.57
262 rdf:type schema:Person
263 sg:person.01153016346.55 schema:affiliation grid-institutes:grid.413514.6
264 schema:familyName Martínez
265 schema:givenName P
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153016346.55
267 rdf:type schema:Person
268 sg:person.01174075722.29 schema:affiliation grid-institutes:None
269 schema:familyName Villuendas
270 schema:givenName R
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174075722.29
272 rdf:type schema:Person
273 sg:person.07440427070.11 schema:affiliation grid-institutes:None
274 schema:familyName Piris
275 schema:givenName MA
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07440427070.11
277 rdf:type schema:Person
278 sg:person.07672372522.34 schema:affiliation grid-institutes:grid.413514.6
279 schema:familyName Mateo
280 schema:givenName M-S
281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07672372522.34
282 rdf:type schema:Person
283 sg:pub.10.1038/381751a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027266776
284 https://doi.org/10.1038/381751a0
285 rdf:type schema:CreativeWork
286 sg:pub.10.1038/sj.leu.2401766 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016032167
287 https://doi.org/10.1038/sj.leu.2401766
288 rdf:type schema:CreativeWork
289 grid-institutes:None schema:alternateName Centro Nacional de Investigaciones Oncologicas, Programa de Patologia Molecular, Instituto de Salud Carlos III, Madrid, Spain
290 schema:name Centro Nacional de Investigaciones Oncologicas, Programa de Patologia Molecular, Instituto de Salud Carlos III, Madrid, Spain
291 rdf:type schema:Organization
292 grid-institutes:grid.413514.6 schema:alternateName Department of Genetics, ‘Virgen de la Salud’ Hospital, Toledo, Spain
293 Department of Pathology, ‘Virgen de la Salud’ Hospital, Toledo, Spain
294 schema:name Department of Genetics, ‘Virgen de la Salud’ Hospital, Toledo, Spain
295 Department of Pathology, ‘Virgen de la Salud’ Hospital, Toledo, Spain
296 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...